Cite
HARVARD Citation
Cazelles, C. et al. (2021). Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation. Leukemia & lymphoma. 62 (9), pp. 2161-2168. [Online].